{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:53Z","timestamp":1759451933923,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.053","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T16:06:47Z","timestamp":1650730007000},"page":"3366-3371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinically proven specification setting for a meningococcal serogroup a conjugate vaccine"],"prefix":"10.1016","volume":"40","author":[{"given":"Valeria","family":"Onnis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Moriconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Paludi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusy","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Aggravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Parlati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Tomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Meppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Cianetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Bufali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2022.04.053_b0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/14712598.2015.993375","article-title":"Glycoconjugate vaccines: an update","volume":"15","author":"Vella","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.053_b0010","first-page":"273","article-title":"Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"45","key":"10.1016\/j.vaccine.2022.04.053_b0015","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/j.vaccine.2012.08.021","article-title":"Relative stability of meningococcal serogroup A and X polysaccharides","volume":"30","author":"Berti","year":"2012","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2022.04.053_b0020","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1016\/j.vaccine.2020.04.005","article-title":"A new strategy for preparing a tailored meningococcal ACWY conjugate vaccine for clinical testing","volume":"38","author":"Moriconi","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.053_b0025","doi-asserted-by":"crossref","first-page":"121143","DOI":"10.1016\/j.ijpharm.2021.121143","article-title":"Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine","volume":"609","author":"Neyra","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.053_b0030","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1981085","article-title":"Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults","volume":"18","author":"D\u00edez-Domingo","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"issue":"45","key":"10.1016\/j.vaccine.2022.04.053_b0035","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1016\/j.vaccine.2021.09.068","article-title":"A new fully liquid presentation of MenACWY-CRM conjugate vaccine: results from a multicentre, randomised, controlled, observer-blind study","volume":"39","author":"Vandermeulen","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.053_b0040","unstructured":"ICH Q6A and Q6B guidelines at https:\/\/www.ich.org\/page\/quality-guidelines."},{"key":"10.1016\/j.vaccine.2022.04.053_b0045","unstructured":"WHO TRS962 A3- Guidelines on stability evaluation of vaccines 2006."},{"key":"10.1016\/j.vaccine.2022.04.053_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2022.02.004","article-title":"Glycoconjugate content quantification to assess vaccine potency: a simplified approach","author":"Rech","year":"2022","journal-title":"Biologicals"},{"issue":"7","key":"10.1016\/j.vaccine.2022.04.053_b0055","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1021\/acsomega.9b01678","article-title":"NMR Assays for estimating the O-Acetyl content of meningococcal polysaccharide serogroup A in quadrivalent conjugate vaccine formulation","volume":"4","author":"Martini","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.vaccine.2022.04.053_b0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chemolab.2014.03.006","volume":"134","author":"Francq","year":"2014","journal-title":"Chemometrics and Intelligent Laboratory Systems"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:11Z","timestamp":1759403591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":12,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004935"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically proven specification setting for a meningococcal serogroup a conjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}